91
Participants
Start Date
May 31, 2007
Primary Completion Date
July 31, 2010
Study Completion Date
December 31, 2010
SB-509
60 mg dose
Placebo
Saline
Peripheral Neuropathy Center, Weill Medical College of Cornell University, New York
Neurological Institute Columbia University College of Physicians and Surgeons, New York
Upstate Clinical Research, Albany
Altoona Center for Clinical Research, Duncansville
Neurology Clinical Research, Sunrise
Laszlo J. Mate', M.D., West Palm Beach
Bradenton Research Center, Bradenton
University of Kansas Medical Center, Kansas City
Creighton Diabetes Center, Omaha
Nerve and Muscle Center of Texas, Houston
DGD Research, San Antonio
Diabetes Center of the Southwest, Midland
Advanced Biomedical Research of America, Las Vegas
Torrance Clinical Research, Lomita
Advanced Medical Research, LLC, Lakewood
Coordinated Clinical Research, La Jolla
SF Clinical Research Center, San Francisco
Diablo Clinical Research, Walnut Creek
Rainier Clinical Research Center, Renton
Instituto Mexicano de Investigación Clinica, Mexico City
Lead Sponsor
Sangamo Therapeutics
INDUSTRY